Kearns Evan
SEC CIK 1745285 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| COGT | Cogent Biosciences, Inc. | CLO | 109.4K | — | $2.52M | 3 | 2025-12-17 | 2025-12-26 |
Most active insiders at COGT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir | — | $370.02M |
| 2 | Robinson John Edward | CSO | — | $3.49M |
| 3 | Sachs Jessica | Chief Medical Off | — | $3.20M |
| 4 | Green John L. | CFO | — | $2.98M |
| 5 | Kearns Evan | CLO | — | $2.52M |
| 6 | Morris Arlene | Dir | — | $1.69M |
| 7 | Pinnow Cole | Chief Commercial Off | — | — |
| 8 | Robbins Andrew R | Pres, CEO, Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-12-26 | COGT | Cogent Biosciences, Inc. | Kearns Evan | CLO | S - Sale | $38.70 | -65.0K | 109.4K | -37% | -$2.52M | |
| DM | 2025-12-19 | 2025-12-17 | COGT | Cogent Biosciences, Inc. | Kearns Evan | CLO | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 |
| D | 2025-12-19 | 2025-12-17 | COGT | Cogent Biosciences, Inc. | Kearns Evan | CLO | F - Tax | $39.45 | -125.6K | 174.4K | -42% | -$4.95M |
Purchase Sale Sale after option exercise All abbreviations